Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1996
11/21/1996DE19543039C1 DNA mols. encoding CD30-specific immunoglobulin variable regions
11/21/1996DE19530272C1 Monoclonal antibody specific for cell-surface glyco-protein MGC-24
11/21/1996CA2227326A1 Carbohydrate-mediated coupling of peptides to immunoglobulins
11/21/1996CA2221727A1 Methods for producing and analyzing biopolymer ladders
11/21/1996CA2221716A1 Methods of use of phthalocyanines to inactivate blood borne parasites
11/21/1996CA2221449A1 Use of il-13 to induce 15-lipoxygenase
11/21/1996CA2221350A1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
11/21/1996CA2221314A1 Use of ribavirin and interferon alpha for the treatment of hepatitis c
11/21/1996CA2221305A1 Gene therapy for effector cell regulation
11/21/1996CA2221303A1 Obesity gene product
11/21/1996CA2221269A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996CA2221234A1 Compositions and methods for inhibiting xenograft rejection
11/21/1996CA2221232A1 Post-translational activation of tgf-.beta.1 involving the tsp-1 receptor cd36
11/21/1996CA2220010A1 Bmp-15 compositions
11/21/1996CA2219984A1 Cell death protein
11/21/1996CA2219487A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996CA2218898A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd19 antibodies
11/21/1996CA2217969A1 Ataxia-telangiectasia gene and its genomic organization
11/21/1996CA2217965A1 Ataxia-telangiectasia gene
11/21/1996CA2217020A1 Recombinant heregulins and their biological functions upon receptor activation
11/21/1996CA2194692A1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase
11/20/1996EP0743321A2 Obesity gene product
11/20/1996EP0743320A2 Acyl guanidine and amidine prodrugs
11/20/1996EP0743319A1 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ace and nep
11/20/1996EP0743318A1 Novel anti-hiv agent
11/20/1996EP0743300A1 15-Deoxyspergualine-related compounds, process for their preparation and their application in therapy
11/20/1996EP0743070A2 Use of protease proenzymes and amylases as active agents in pharmaceutical compositions for cancer therapy and their preparation
11/20/1996EP0743069A1 Pharmaceutical compositions for migraine treatment
11/20/1996EP0743066A2 Wound-healing agent
11/20/1996EP0743060A1 Mouth-care products
11/20/1996EP0742834A1 Method of preparing a viral vector by homologous intermolecular recombination
11/20/1996EP0742833A1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies
11/20/1996EP0742831A1 Transgenic non-human mammals with progressive neurologic disease
11/20/1996EP0742830A1 Fusion proteins that include antibody and nonantibody portions
11/20/1996EP0742826A1 Multivariant il-3 hematopoiesis fusion protein
11/20/1996EP0742825A1 Cloning and recombinant production of crf receptor(s)
11/20/1996EP0742823A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
11/20/1996EP0742818A1 Macroencapsulated secretory cells
11/20/1996EP0742796A1 Il-3 variant hematopoiesis fusion protein
11/20/1996EP0742795A1 Immuno-stimulatory monoclonal antibodies
11/20/1996EP0742794A1 Interleukin-6 (il-6) antagonists
11/20/1996EP0742793A1 Bcl-2-associated proteins
11/20/1996EP0742791A1 Macrocyclic difluorostatone derivatives useful as antiviral agents
11/20/1996EP0742790A1 Substituted purines and oligonucleotide cross-linking
11/20/1996EP0742789A1 Pharmaceutically active compounds and liposomes, and methods of use therof
11/20/1996EP0742723A1 Homologous recombination for universal donor cells and chimeric mammalian hosts
11/20/1996EP0742722A1 Method for increasing bioavailability of oral pharmaceutical compositions
11/20/1996EP0742721A1 Methods of prolonged suppression of humoral immunity
11/20/1996EP0742720A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
11/20/1996EP0656783B1 Pharmaceuticals containing onconase and cisplatin, melphalan and adriamycin
11/20/1996EP0596943B1 Process for purifying pentostatin
11/20/1996EP0489767B1 Cck antagonists
11/20/1996EP0479916B1 Gamma retinoic acid receptor
11/20/1996CN1136327A Using antisense oligonucleotides to modulate nerve growth and to reverse 'beta'/A4 amyloid-induced morphology
11/20/1996CN1136278A Combination of bisphosphonates and growth hormone secretagogues
11/20/1996CN1136043A Human interleukin-6 inhibitor
11/20/1996CN1033330C Calcium channel blocking polypeptides from theraphosidae aphonopelma
11/19/1996US5576423 Antibodies to the slam protein expressed on activated T cells
11/19/1996US5576420 Subtilin variant of enhanced stability and activity
11/19/1996US5576330 Mixture of an angiogenesis inhibitor and an antitumor agent
11/19/1996US5576326 Antitumor
11/19/1996US5576305 Intercellular adhesion mediators
11/19/1996US5576301 Low molecular growth potentiating peptides
11/19/1996US5576300 Method for inhibition of human rotavirus infection
11/19/1996US5576299 Lactoferrin
11/19/1996US5576298 Peptides from pseudomonas syringae possessing broad-spectrum antibiotic activity
11/19/1996US5576297 Embodiments of natural and synthetic lethal toxin neutralizing factors and their utility as treatment for envenomation
11/19/1996US5576296 Galanin antagonist
11/19/1996US5576295 Agent for suppressing the motor activity of gastrointestinal tracts
11/19/1996US5576294 Polypeptides as enzyme inhibitors
11/19/1996US5576293 Inhibitors of farnesyl-protein transferase
11/19/1996US5576292 Biologically active bactericidal/permeability-increasing protein fragments
11/19/1996US5576291 Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
11/19/1996US5576290 Compositions and methods for the diagnosis and treatment of psychogenic erectile dysfunction
11/19/1996US5576289 Methods for treating motor deficits
11/19/1996US5576287 Method for treating acute renal disease and failure
11/19/1996US5576209 Method for increasing the resistance of neural cells to β-amyloid peptide toxicity
11/19/1996US5576208 Antisense oligonucleotide inhibition of the RAS gene
11/19/1996US5576195 Dna coding; preparing immunoglobulins
11/19/1996US5576193 Protein having human plasmin inhibiting activity
11/19/1996US5576184 Production of chimeric mouse-human antibodies with specificity to human tumor antigens
11/19/1996US5576026 Lumbricus product and method of making same
11/19/1996US5576002 Meningococcal polysaccharide conjugate vaccine
11/19/1996US5575987 Method of producing sustained-release microcapsules
11/19/1996CA2176414A1 Acyl guanidine and amidine prodrugs
11/19/1996CA1338728C Cyclosporins and their use a pharmaceuticals
11/19/1996CA1338722C Gamma-interferon for the treatment of vascular stenosis
11/18/1996CA2176415A1 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ace and nep
11/14/1996WO1996035951A1 Novel peptides and compositions which modulate apoptosis
11/14/1996WO1996035950A1 Inhibition of amylin release
11/14/1996WO1996035813A1 A transition in transcriptional activation by intracellular hormone receptors at the tumor stage of dermal fibrosarcoma development
11/14/1996WO1996035808A1 Methods for detection and therapy of squamous cell carcinoma and bladder carcinoma, in particular for determining the presence and treatment of minimal residual disease, micrometastases or dissemination of such carcinoma types
11/14/1996WO1996035805A2 Tripeptidylpeptidase inhibitors
11/14/1996WO1996035791A1 Dna sequence, coding for a ribozyme, useful as a drug, and pharmaceutical compositions containing same
11/14/1996WO1996035789A1 Human interferon tau compositions and methods of use
11/14/1996WO1996035788A2 Kunitz type protease inhibitors
11/14/1996WO1996035787A1 Nucleic acids for treating obesity
11/14/1996WO1996035785A2 Transgenic animals having a defective thyroid hormone receptor beta gene
11/14/1996WO1996035784A2 Chromatin-regulator genes
11/14/1996WO1996035783A1 Methods of preparing soluble, oligomeric proteins
1 ... 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 ... 3163